No content here.

Anivive

Booth: 206
  • | Pharmaceutical

Anivive is reinventing the drug development process in pet pharma with a pipeline of 8+ first-in-class pharmaceuticals, biologics, and vaccines. Our proprietary software accelerates the delivery of breakthrough treatments for pets’ biggest unmet medical needs. Anivive’s LAVERDIA™-CA1 (verdinexor) is the first conditionally approved oral tablet to treat canine lymphoma.

To learn more visit: www.anivive.com.

Address

3750 Schaufele Avenue
Long Beach
CA
90808
United Kingdom
Visit website
Contact Exhibitor

Contact Exhibitor


Loading
View all Exhibitors

Join the Paw-ty! Sign up for our newsletter: